{"product_id":"semaglutide-5mg-10mg-research-peptide","title":"Semaglutide 5mg\/10mg Research Peptide","description":"\u003ch2 class=\"mb-4 font-heading text-xl font-bold text-white\"\u003eProduct Details\u003c\/h2\u003e\n\u003cdiv class=\"prose-shopify max-w-none\"\u003e\n\u003cp\u003e\u003cstrong\u003eFor Research Purposes Only.\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eNot approved for human consumption.\u003c\/p\u003e\n\u003ch2\u003eSemaglutide Research Peptide 5mg\u003c\/h2\u003e\n\u003cp\u003eSemaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist developed by Novo Nordisk, representing the current standard for single-mechanism metabolic peptide research. It mimics endogenous GLP-1 with 94% homology but with extended half-life (~165 hours) due to albumin binding via a C-18 fatty di-acid side chain. With extensive Phase 3 data across diabetes (SUSTAIN trials) and obesity (STEP trials), Semaglutide serves as a benchmark comparator for researchers studying newer metabolic peptides including Tirzepatide and Retatrutide.\u003c\/p\u003e\n\u003ch2\u003eResearch Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eGLP-1 receptor biology and signaling research\u003c\/li\u003e\n\u003cli\u003eDiabetes and glucose metabolism studies\u003c\/li\u003e\n\u003cli\u003eObesity and weight regulation research\u003c\/li\u003e\n\u003cli\u003eGastric motility and satiety mechanism studies\u003c\/li\u003e\n\u003cli\u003eComparative metabolic peptide efficacy studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eQuality Specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003ePurity: ≥98% (HPLC verified)\u003c\/li\u003e\n\u003cli\u003eCompound: Semaglutide\u003c\/li\u003e\n\u003cli\u003eMolecular Weight: 4113.6 Da\u003c\/li\u003e\n\u003cli\u003eForm: Lyophilized powder\u003c\/li\u003e\n\u003cli\u003eStorage: -20°C, protect from light\u003c\/li\u003e\n\u003cli\u003eCOA: Batch-specific, ISO-accredited laboratory\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How does Semaglutide differ from native GLP-1?\u003c\/strong\u003e\u003cbr\u003eA: 94% homology to human GLP-7-37 but with a C-18 fatty di-acid side chain enabling albumin binding. This extends half-life from minutes to ~165 hours, allowing weekly administration in research.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What is Semaglutide's research significance?\u003c\/strong\u003e\u003cbr\u003eA: Extensive Phase 3 data makes it the benchmark GLP-1 agonist. Researchers use it as a comparator when studying newer compounds like Tirzepatide (dual agonist) and Retatrutide (triple agonist).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How does Semaglutide work mechanically?\u003c\/strong\u003e\u003cbr\u003eA: Activates GLP-1 receptors in the pancreas (glucose-dependent insulin secretion), hypothalamus (appetite regulation), and GI tract (delayed gastric emptying).\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Simple Research Peptides LLC","offers":[{"title":"Semaglutide 10mg Research Peptide","offer_id":45804020367394,"sku":null,"price":130.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0878\/4478\/2114\/files\/semaglutide-5mg10mg-research-peptide-9584968.png?v=1782099787","url":"https:\/\/simpleresearchpeptides.com\/products\/semaglutide-5mg-10mg-research-peptide","provider":"Simple Research Peptides","version":"1.0","type":"link"}